BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16944348)

  • 1. MRI findings in benign multiple sclerosis are variable.
    Pittock SJ; Noseworthy JH; Rodriguez M
    J Neurol; 2007 Apr; 254(4):539-41. PubMed ID: 16944348
    [No Abstract]   [Full Text] [Related]  

  • 2. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
    Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A magnetic resonance imaging investigation into mood disorders in multiple sclerosis: a pilot study.
    George MS; Kellner CH; Bernstein H; Goust JM
    J Nerv Ment Dis; 1994 Jul; 182(7):410-2. PubMed ID: 8021642
    [No Abstract]   [Full Text] [Related]  

  • 4. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D; Miller D
    J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.
    Maghzi AH; Revirajan N; Julian LJ; Spain R; Mowry EM; Liu S; Jin C; Green AJ; McCulloch CE; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2014 Nov; 3(6):720-7. PubMed ID: 25891551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathological symptoms and magnetic resonance imaging findings in multiple sclerosis.
    Reischies FM; Baum K; Nehrig C; Schörner W
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):676-8. PubMed ID: 8329501
    [No Abstract]   [Full Text] [Related]  

  • 8. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--no.
    Filippi M; Rocca MA
    Mult Scler; 2012 May; 18(5):557-8. PubMed ID: 22547411
    [No Abstract]   [Full Text] [Related]  

  • 9. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--yes.
    Geurts JJ
    Mult Scler; 2012 May; 18(5):559-60. PubMed ID: 22547412
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
    Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
    J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral magnetic resonance imaging findings in multiple sclerosis. Relation to disturbance of affect, drive, and cognition.
    Reischies FM; Baum K; Bräu H; Hedde JP; Schwindt G
    Arch Neurol; 1988 Oct; 45(10):1114-6. PubMed ID: 3178531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: MRI and clinical correlation.
    Edwards MK; Farlow MR; Stevens JC
    AJR Am J Roentgenol; 1986 Sep; 147(3):571-4. PubMed ID: 3488658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis.
    Giugni E; Pozzilli C; Bastianello S; Gasperini C; Paolillo A; Koudriavtseva T; Frontoni M; Farina D; Bozzao L
    Mult Scler; 1997 Aug; 3(4):221-5. PubMed ID: 9372503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and degree of disability in multiple sclerosis.
    Kiel MK; Greenspun B; Grossman RI
    Arch Phys Med Rehabil; 1988 Jan; 69(1):11-3. PubMed ID: 3337635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time.
    Jacobi C; Hähnel S; Martinez-Torres F; Rieger S; Jüttler E; Heiland S; Jarius S; Meyding-Lamadè U; Storch-Hagenlocher B; Wildemann B
    Eur J Neurol; 2008 Dec; 15(12):1359-64. PubMed ID: 19049554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND; Kraft E; Stüve O
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis and the cerebellum.
    Tornes L; Conway B; Sheremata W
    Neurol Clin; 2014 Nov; 32(4):957-77. PubMed ID: 25439291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal imaging: change and causality.
    Whitwell JL
    Curr Opin Neurol; 2008 Aug; 21(4):410-6. PubMed ID: 18607200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUSIS 2.0 - Multiple Sclerosis Information System: An easy-to-use-database to improve the care of patients with multiple sclerosis.
    Schröder M
    Mult Scler; 1999 Aug; 5(4):299-301. PubMed ID: 10467394
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI and cognition in multiple sclerosis.
    Filippi M; Rocca MA
    Neurol Sci; 2010 Nov; 31(Suppl 2):S231-4. PubMed ID: 20635114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.